In a recent testimony before the House of Representatives Committee on Oversight and Accountability, FDA Commissioner Robert Califf addressed key issues surrounding the long-awaited decision on rescheduling cannabis by the Drug Enforcement Administration (DEA). The remarks by Califf, analyzed by Pablo Zuanic of Zuanic & Associates, offer insights into the complexities and potential pathways forward … Continue reading Will the US Only Legalize Medical Cannabis First?